VIG vs XLV
Vanguard Dividend Appreciation ETF vs Health Care Select Sector SPDR Fund
- • VIG has the lower expense ratio at 0.04% vs 0.08% for XLV.
- • VIG pays a higher dividend yield (1.47%).
Side-by-side metrics
| Metric | VIG | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.47% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $135.70B | $49.10B |
YTD return | 14.79% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.70 | 0.41 |
P/E ratio | 26.31 | 30.63 |
Last price | $251.63 | $187.94 |
Inception | — | — |
Issuer | Vanguard | State Street |
VIG top holdings
| MSFT | Microsoft Corp | 4.91% |
| AAPL | Apple Inc | 4.89% |
| AVGO | Broadcom Inc | 4.30% |
| LLY | Eli Lilly and Co | 4.10% |
| JPM | JPMorgan Chase & Co | 3.90% |
| XOM | ExxonMobil Holdings Corp | 2.97% |
| JNJ | Johnson & Johnson | 2.83% |
| V | Visa Inc Class A | 2.53% |
| WMT | Walmart Inc | 2.05% |
| ABBV | AbbVie Inc | 2.05% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About VIG
VIG (Vanguard Dividend Appreciation ETF) is US companies with a record of growing dividends. Managed by Vanguard, the fund carries $135.7B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.47%. Its largest holding is Microsoft Corp (MSFT), which represents 4.9% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 3.9%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.